Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.3.16 (
calcineurin
)
17,112
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We have cloned and characterized a human cDNA, designated
N4WBP5A
, that belongs to the family of Nedd4-binding proteins. We originally identified
N4WBP5A
as an unknown expressed sequence tag (AA770150) represented in a cDNA microarray analysis that was up-regulated upon activation of T cells and inhibited by cell treatment with the
calcineurin
phosphatase inhibitors, cyclosporine (CsA) and tacrolimus (FK506). The predicted
N4WBP5A
amino acid sequence of 242 amino acid residues reveals an open reading frame of 729 nucleotides with a corresponding molecular mass of 27.1 kDa. Detection of
N4WBP5A
mRNA by reverse transcription-PCR was consistent with the induction of
N4WBP5A
following mitogenic stimulation of T lymphocytes and inhibition by CsA. Immunoblot analysis revealed endogenous
N4WBP5A
protein to be up-regulated following T cell activation and inhibited by CsA. This regulation of
N4WBP5A
mRNA expression differed from that of its homologue (51% identical; 65% similar) N4WBP5. Like N4WBP5, however, expression of epitope-tagged
N4WBP5A
indicated that the protein is localized predominantly to the Golgi network. Here we show by co-precipitation experiments that
N4WBP5A
interacts with the WW domains of Nedd4, an E3 ubiquitin ligase. Taken together, our data suggest that
N4WBP5A
may play a regulatory role in modulating Nedd4 activity at the level of the Golgi apparatus in T lymphocytes.
...
PMID:Cloning and characterization of N4WBP5A, an inducible, cyclosporine-sensitive, Nedd4-binding protein in human T lymphocytes. 1279 89